Investor caution is advised as Suzhou Zelgen Biopharmaceutic...

Moomoo AI Dec 22, 2023 04:21

Investor caution is advised as Suzhou Zelgen Biopharmaceuticals' high P/S and less than stellar revenue forecasts could indicate a potential downturn in share price.

Some Confidence Is Lacking In Suzhou Zelgen Biopharmaceuticals Co., Ltd.'s (SHSE:688266) P/S

Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more

Translate

Report

556 Views

Comment

Moomoo AI

Moomoo AI Official Account

Your AI assistant for discovering investment opportunities.

3555Followers

0Following

8388Visitors